Found: 26
Select item for more details and to access through your institution.
The function of LncRNA-ATB in cancer.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 1, doi. 10.1007/s12094-022-02848-1
- By:
- Publication type:
- Article
BRAF/MEK inhibition in NSCLC: mechanisms of resistance and how to overcome it.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 10, doi. 10.1007/s12094-022-02849-0
- By:
- Publication type:
- Article
LncRNA MALAT1-related signaling pathways in osteosarcoma.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 21, doi. 10.1007/s12094-022-02876-x
- By:
- Publication type:
- Article
The role of LncRNA MCM3AP-AS1 in human cancer.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 33, doi. 10.1007/s12094-022-02904-w
- By:
- Publication type:
- Article
Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 48, doi. 10.1007/s12094-022-02914-8
- By:
- Publication type:
- Article
NIMA-related kinase-6 (NEK6) as an executable target in cancer.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 66, doi. 10.1007/s12094-022-02926-4
- By:
- Publication type:
- Article
Nanoimmunoengineering strategies in cancer diagnosis and therapy.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 78, doi. 10.1007/s12094-022-02935-3
- By:
- Publication type:
- Article
The pleiotropic mode and molecular mechanism of macrophages in promoting tumor progression and metastasis.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 91, doi. 10.1007/s12094-022-02932-6
- By:
- Publication type:
- Article
A research review of experimental animal models with myelodysplastic syndrome.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 105, doi. 10.1007/s12094-022-02931-7
- By:
- Publication type:
- Article
Application of tumor-educated platelets as new fluid biopsy markers in various tumors.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 114, doi. 10.1007/s12094-022-02937-1
- By:
- Publication type:
- Article
Biomarkers for immune checkpoint inhibitors in solid tumors.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 126, doi. 10.1007/s12094-022-02942-4
- By:
- Publication type:
- Article
The crucial role of LncRNA MIR210HG involved in the regulation of human cancer and other disease.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 137, doi. 10.1007/s12094-022-02943-3
- By:
- Publication type:
- Article
Physicians' attitudes and perceived barriers to adherence to the national breast cancer clinical practice guidelines in Mexico: a survey study.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 151, doi. 10.1007/s12094-022-02921-9
- By:
- Publication type:
- Article
Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 160, doi. 10.1007/s12094-022-02922-8
- By:
- Publication type:
- Article
Tumor mutational burden and efficacy of chemotherapy in lung cancer.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 173, doi. 10.1007/s12094-022-02924-6
- By:
- Publication type:
- Article
Blockade of exosome release alters HER2 trafficking to the plasma membrane and gives a boost to Trastuzumab.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 185, doi. 10.1007/s12094-022-02925-5
- By:
- Publication type:
- Article
Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 199, doi. 10.1007/s12094-022-02923-7
- By:
- Publication type:
- Article
The correlations between psychological distress, cognitive impairment and quality of life in patients with brain metastases after whole-brain radiotherapy.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 207, doi. 10.1007/s12094-022-02927-3
- By:
- Publication type:
- Article
DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 218, doi. 10.1007/s12094-022-02930-8
- By:
- Publication type:
- Article
Pre-radiotherapy systemic immune inflammation index associated with overall survival in patients with advanced EGFR mutant non-small cell lung cancer receiving thoracic radiotherapy.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 226, doi. 10.1007/s12094-022-02936-2
- By:
- Publication type:
- Article
Discontinuation of mechanical bowel preparation in advanced ovarian cancer surgery: an enhanced recovery after surgery (ERAS) initiative.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 236, doi. 10.1007/s12094-022-02934-4
- By:
- Publication type:
- Article
NEDD4L represses prostate cancer cell proliferation via modulating PHF8 through the ubiquitin–proteasome pathway.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 243, doi. 10.1007/s12094-022-02933-5
- By:
- Publication type:
- Article
Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the CLAP trial.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 256, doi. 10.1007/s12094-022-02945-1
- By:
- Publication type:
- Article
Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 269, doi. 10.1007/s12094-022-02940-6
- By:
- Publication type:
- Article
A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 1, p. 283, doi. 10.1007/s12094-022-02941-5
- By:
- Publication type:
- Article
Correction to: Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice